نتایج جستجو برای: telmisartan

تعداد نتایج: 1323  

Journal: :Journal of the American Society of Hypertension : JASH 2013
Hisato Takagi Masao Niwa Yusuke Mizuno Shin-nosuke Goto Takuya Umemoto

Telmisartan has been proposed to be a promising cardiometabolic sartan due to its unique peroxisome proliferator-activated receptor-gamma-inducing property. To determine whether telmisartan improves metabolic parameters in metabolic syndrome, we perform the first meta-analysis of randomized controlled trials (RCTs). MEDLINE, EMBASE, and the Cochrane Central Register of Controlled Trials were se...

2017
Catherine N. Le Todd Hulgan Chi-Hong Tseng Ginger L. Milne Jordan E. Lake

OBJECTIVES Arachidonic acid metabolites (eicosanoids) reflect oxidative stress and vascular health and have been associated with anthropometric measures and sex differences in cross-sectional analyses of HIV-infected (HIV+) persons. Telmisartan is an angiotensin receptor blocker and PPAR-γ agonist with potential anti-inflammatory and metabolic benefits. We assessed telmisartan's effects on urin...

2013
Keiji Ozeki Satoshi Tanida Chie Morimoto Yoshimasa Inoue Tsutomu Mizoshita Hironobu Tsukamoto Takaya Shimura Hiromi Kataoka Takeshi Kamiya Eiji Nishiwaki Hiroshi Ishiguro Shigeki Higashiyama Takashi Joh

BACKGROUND AIMS Current treatment target toward advanced colorectal cancers is mainly focused on the epidermal growth factor receptor (EGFR) signaling, but its additive effects with chemotherapy are still limited. A disintegrin and metalloproteinase (ADAM) cleaves the proheparin-binding epidermal growth factor like growth factor (proHB-EGF). And soluble HB-EGF activates EGFR. In parallel, the c...

Journal: :Advances in therapy 2012
Steen Neldam Helmut Schumacher Robert Guthrie

INTRODUCTION Most patients with hypertension require combination therapy to achieve optimal reduction of blood pressure (BP). The angiotensin II receptor blocker, telmisartan, provides 24-hour BP-lowering efficacy and is proven to prevent cardiovascular morbidity in high-risk patients. METHODS Pooled data from seven randomized controlled trials (3,654 patients with stage 1-2 hypertension) wer...

2018
Woo Youl Kang Sook Jin Seong Boram Ohk Mi-Ri Gwon Bo Kyung Kim Sookie La Hyun-Ju Kim Seungil Cho Young-Ran Yoon Dong Heon Yang Hae Won Lee

Purpose A new fixed-dose combination (FDC) formulation of telmisartan 80 mg and S-amlodipine 5 mg (CKD-828) has been developed to increase convenience (as only one tablet is required per day) and improve treatment compliance. Methods The pharmacokinetic characteristics and tolerability of an FDC of telmisartan and S-amlodipine were compared to those after coadministration of the individual ag...

Journal: :Journal of clinical and diagnostic research : JCDR 2014
Pushpa V H Padmaja Shetty K Suresha R N Jayanthi M K Ashwini V Vaibhavi P S

BACKGROUND Epilepsy is one common neurological disorder requiring newer targets and newer drugs for its efficient management. In the recent days brain renin angiotensin system has gained immense importance because of its involvement in seizure regulation. OBJECTIVE To evaluate and compare antiepileptic activity of different doses olmesartan and telmisartan on MES and PTZ induced seizure model...

Journal: :Polskie Archiwum Medycyny Wewnetrznej 2013
Sławomir Lizakowski Leszek Tylicki Przemysław Rutkowski Marcin Renke Beata Sulikowska Zbigniew Heleniak Rafał Donderski Rafał Bednarski Milena Przybylska Jacek Manitius Bolesław Rutkowski

INTRODUCTION Various methods of combination renin-angiotensin-aldosterone system blockade help achieve more potent antiproteinuric effects, but may be associated with higher risk of side effects. Therapies involving direct renin inhibitor, aliskiren, may promote renal fibrosis by stimulating (pro)renin receptor due to increased renin levels. OBJECTIVES The aim of the study was to compare the ...

Journal: :Journal of cardiovascular pharmacology 2007
Ralf A Benndorf Daniel Appel Renke Maas Edzard Schwedhelm Ulrich O Wenzel Rainer H Böger

BACKGROUND : Hypertension is a cardiovascular risk factor commonly associated with endothelial dysfunction and increased renal vascular resistance. Angiotensin receptor blockers (ARBs) may beneficially affect these parameters via antagonism of angiotensin type 1 (AT1) receptor-mediated vasoconstriction and vascular superoxide production. We therefore investigated whether the new ARB telmisartan...

2014
C. Di Filippo C. Rossi B. Ferraro R. Maisto A. De Angelis F. Ferraraccio A. Rotondo M. D'Amico

This study investigated the involvement of proteasome and macrophages M2 in the protection afforded by telmisartan against the acute myocardial infarction in Zucker diabetic fatty (ZDF) rats with metabolic syndrome. ZDF rats were treated for three weeks with telmisartan at doses of 7 and 12 mg/kg/day. After treatment, rats were subjected to a 25 min occlusion of the left descending coronary art...

Journal: :Saudi medical journal 2011
Gao-Zhong Huang Ye-Hua Tang Bei-Yun Wang Bei Zhang Ting-Jun Hu Li Zhang Xiao-Yan Zhang Yuan Zhong

OBJECTIVE To investigate the effects of telmisartan on body fat distribution and insulin sensitivity in patients with hypertension and obesity. METHODS In this prospective, randomized study, outpatients from the Sixth People's Hospital affiliated to Shanghai Jiaotong University, Shanghai, China were treated with telmisartan (n=23), or losartan (n=22) for 16 weeks between December 2009 to Janu...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید